Omar Boraie Funds Chair For Genomic Science At Rutgers

Rutgers University is adding 18 new chairs as part of an “18 Chair Challenge” campaign. These chairs are $1.5 million endowments that will fund groundbreaking research in the field of cancer research and treatment. Rutgers Cancer Institute of New Jersey has just established the Omar Boraie Chair in Genomic Science. Omar Boraie is a New Brunswick developer who has endowed the funds to support genetic research and personalized management. As a developer in New Brunswick, Omar Boraie has been an integral part in the makeover the “Healthcare City”.

No cancer is the same and scientists in the genomic science field are making extraordinary discoveries leading to more individualized cancer treatments. Genomic science and precision medicine is revolutionizing cancer treatment by tackling cancer on a genetic level. Doctors are able to use these new approaches for difficult and previously non-treatable cancers and are seeings better outcomes.

In a recent State of the Union address, President Obama spoke of the wonders of genomic science and announced the launch of a national Precision Medicine Initiative. The focus of this initiative is to find a cure for cancer and other diseases that can be best tackled on a smaller scale, personalized level. Physician-scientists are the movers and shakers in the newly established field of genomic science and are providing hope to those who have previously been diagnosed as non-treatable or inoperable. Rutgers University was the only facility in the state of New Jersey and one of the first of its kind in the country to use genomic sequencing to tackle cancer with a personalized approach with precision medicine.

The Omar Boraie Chair in Genomic Science has been named to Shridar Ganesan, MD, PhD. Ganesan is the principle investigator of the medicine clinical trial being conducted at Rutgers, and an associate professor of medicine and pharmacology who has been at the Cancer Institute since 2005. Ganesan says “I am honored to be named the Omar Boraie Chair in Genomic Science. This pledge will help innovate clinical research to enable new understandings of cancer biology to benefit patients across even the most challenging disease sites, offering renewed hope for cancer patients and their families.”

As part of Omar Boraie’s plan for the redevelopment of New Brunswick, the Omar Chair in Genomic Science further shows his support for the medical field and the city he loves. NewsWise has more on this story, originally reported by them.

Leave a Reply